表紙
市場調查報告書
商品編碼
1028861

全球癌症的生技藥品市場報告:2021年版 - COVID-19擴大和2030年的變化

Cancer biologics Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球癌症的生技藥品市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 癌症的生技藥品市場特徵

第3章 癌症的生技藥品市場趨勢與策略

第4章 COVID-19癌症生技藥品的影響

第5章 癌症的生技藥品的市場規模與成長

  • 全球癌症的生技藥品市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球癌症的生技藥品預測市場,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 癌症的生技藥品市場區隔

  • 全球癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 單株抗體
  • 疫苗
  • 細胞及基因治療
  • 其他
  • 全球癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 醫院
  • 診所
  • 其他

第7章 癌症的生技藥品市場各地區以及各國分析

  • 全球癌症的生技藥品市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球癌症的生技藥品市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的癌症的生技藥品市場

  • 亞太地區的癌症的生技藥品市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的癌症的生技藥品市場

  • 中國的癌症的生技藥品市場概要
  • 中國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的癌症的生技藥品市場

  • 印度的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的癌症的生技藥品市場

  • 日本的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020,2020∼2025年,2030年,10億美元
  • 日本的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020,2020∼2025年,2030年,10億美元

第12章 澳洲的癌症的生技藥品市場

  • 澳洲的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的癌症的生技藥品市場

  • 印尼的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的癌症的生技藥品市場

  • 韓國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的癌症的生技藥品市場

  • 西歐的癌症的生技藥品市場概要
  • 西歐的癌症生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020,2020∼2025年,2030年,10億美元
  • 西歐的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的癌症的生技藥品市場

  • 英國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的癌症的生技藥品市場

  • 德國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的癌症的生技藥品市場

  • 法國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的癌症的生技藥品市場

  • 東歐的癌症的生技藥品市場概要
  • 東歐的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的癌症的生技藥品市場

  • 俄羅斯的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的癌症的生技藥品市場

  • 北美的癌症的生技藥品市場概要
  • 北美的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的癌症的生技藥品市場

  • 美國的癌症的生技藥品市場概要
  • 美國的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的癌症生技藥品市場

  • 南美的癌症生技藥品市場概要
  • 南美的癌症生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020,2020∼2025年,2030年,10億美元
  • 南美的癌症生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020,2020∼2025年,2030年,10億美元

第24章 巴西的癌症的生技藥品市場

  • 巴西的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的癌症的生技藥品市場

  • 中東的癌症的生技藥品市場概要
  • 中東的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的癌症的生技藥品市場

  • 非洲的癌症的生技藥品市場概要
  • 非洲的癌症的生技藥品市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的癌症的生技藥品市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 癌症的生技藥品市場競爭情形和企業簡介

  • 癌症的生技藥品市場競爭情形
  • 癌症的生技藥品市場企業簡介
    • AbbVie Inc.
    • Hoffman-La Roche
    • GlaxoSmithKline
    • Eli Lilly and Company
    • Amgen, Inc.

第28章 癌症的生物製藥開發平台分析

第29章 癌症的生技藥品市場上主要合併和收購

第30章 癌症的生技藥品市場未來展望和潛在性分析

第31章 附錄

目錄
Product Code: h885

Cancer biologics Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global cancer biologics market.

The report focuses on the cancer biologics market which is experiencing strong growth. The report gives a guide to the cancer biologics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer biologics Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Vaccines; Cell And Gene Therapy; Others

2) By Application: Hospitals; Clinics; Others

Companies Mentioned: AbbVie; Hoffman-La Roche; GlaxoSmithKline; Eli Lilly and Company; Amgen

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer biologics Market Characteristics

3. Cancer biologics Market Trends And Strategies

4. Impact Of COVID-19 On Cancer biologics

5. Cancer biologics Market Size And Growth

  • 5.1. Global Cancer biologics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer biologics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer biologics Market Segmentation

  • 6.1. Global Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal antibodies
  • Vaccines
  • Cell and gene therapy
  • Others
  • 6.2. Global Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Others

7. Cancer biologics Market Regional And Country Analysis

  • 7.1. Global Cancer biologics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cancer biologics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer biologics Market

  • 8.1. Asia-Pacific Cancer biologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer biologics Market

  • 9.1. China Cancer biologics Market Overview
  • 9.2. China Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer biologics Market

  • 10.1. India Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer biologics Market

  • 11.1. Japan Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer biologics Market

  • 12.1. Australia Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer biologics Market

  • 13.1. Indonesia Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer biologics Market

  • 14.1. South Korea Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer biologics Market

  • 15.1. Western Europe Cancer biologics Market Overview
  • 15.2. Western Europe Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer biologics Market

  • 16.1. UK Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer biologics Market

  • 17.1. Germany Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer biologics Market

  • 18.4. France Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer biologics Market

  • 19.1. Eastern Europe Cancer biologics Market Overview
  • 19.2. Eastern Europe Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer biologics Market

  • 20.1. Russia Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer biologics Market

  • 21.1. North America Cancer biologics Market Overview
  • 21.2. North America Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer biologics Market

  • 22.1. USA Cancer biologics Market Overview
  • 22.2. USA Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer biologics Market

  • 23.1. South America Cancer biologics Market Overview
  • 23.2. South America Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer biologics Market

  • 24.1. Brazil Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer biologics Market

  • 25.1. Middle East Cancer biologics Market Overview
  • 25.2. Middle East Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer biologics Market

  • 26.1. Africa Cancer biologics Market Overview
  • 26.2. Africa Cancer biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cancer biologics Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer biologics Market Competitive Landscape And Company Profiles

  • 27.1. Cancer biologics Market Competitive Landscape
  • 27.2. Cancer biologics Market Company Profiles
    • 27.2.1. AbbVie Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Hoffman-La Roche
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. GlaxoSmithKline
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Eli Lilly and Company
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Amgen, Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cancer biologics Pipeline Analysis

29. Key Mergers And Acquisitions In The Cancer biologics Market

30. Cancer biologics Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer